Alanine Transaminase levels in Patients of Dengue Fever in the Suburbs of Islamabad
Introduction: Hepatic dysfunction is a highly varied condition that can show up as minor damage with elevated levels of transaminases, or appear as extensive damage and failure of liver cells. Thus, in order to reduce associated morbidity and mortality, this ailment should be diagnosed at the earliest possible so that appropriate therapy can be instituted. Our study was carried out to observe hepatic damage in patients with dengue fever (DF) by measuring alanine transaminase levels.
Materials and Methods: A cross-sectional study of three months duration was carried out in the Department of Medicine, Dr. Akbar Niazi Teaching Hospital affiliated with Islamabad Medical & Dental College, Pakistan. The sampling technique was Non-Random consecutive sampling and 118 patients were included in our study. Serum Alanine Transaminase (ALT) (normal = 7-56 IU/L), serum Aspartate Transaminase (AST) (normal = 10-40 IU/L) were determined and ultra-sound abdomen was performed. Statistical analysis was done using SPSS Version 24. The Chi-square test was used to observe the relationship between categorical variables. Phi, Cramer’s V, Pearson’s, and Spearman’s Correlation tests were used to study the association of age and gender with ALT levels.
Results: There were 72% males (n=85) and 28% females (n=33). Patients were grouped according to age and mean ALT (95+86 IU/L) and AST (134.7+ 98 IU/L) levels were calculated in the different age groups. These levels were found to be significantly raised (P=0.00) in the age groups of 9-18 years and 19-25 years as compared to the other age groups. Moreover, males had high ALT levels as compared to females, however, a significant difference was not observed. There was also no association seen of gender with raised ALT levels (P=0.564), Phi & Cramer’s V=0.56, and Spearman’s correlation coefficient=0.320.
Conclusions: ALT and AST levels were elevated above the normal in our sample indicating hepatic involvement.
2. Dengue and severe dengue WHO.https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue
3. Kalenahalli Jagadishkumar, MBBS, MD,* Puja Jain, MBBS, Vaddambal G. Manjunath, MBBS, DCH, DNB, and Lingappa Umesh, Hepatic Involvement in Dengue Fever in Children - NCBI Iran J Pediatr. 2012 Jun; 22(2): 231–236
4. Dengue Fever/ Programmes/ Pakistan- WHO EMRO http://www.emro.who.int/pak/programmes/dengue-fever.html
5. Khan J, Khan I, Ghaffar A, Khalid B. Epidemiological trends and risk factors associated with dengue disease in Pakistan (1980–2014): a systematic literature search and analysis. BMC public health. 2018 Dec 1;18(1):745.
6. Kalenahalli Jagadishkumar , MBBS, MD,* Puja Jain, MBBS, Vaddambal G. Manjunath, MBBS, DCH, DNB, and Lingappa Umesh, Hepatic Involvement in Dengue Fever in Children Iran J Pediatr. 2012 Jun; 22(2): 231–236.
7. Petdachai W. Hepatic dysfunction in children with dengue shock syndrome. Dengue Bulletin. 2005;29: 112–7.
8. Itha S, Kashyap R, Krishnani N, Saraswat VA, Choudhuri G, Aggarwal R Profile of liver involvement in dengue virus infection. Natl Med J India. 2005 May-Jun; 18(3):127-30
9. Khan E, Kisat M, Khan N, Nasir A, Ayub S, Hasan R. Demographic and clinical features of dengue fever in Pakistan from 2003–2007: a retrospective cross-sectional study. PloS one. 2010;5(9).
10. Gubler DJ, Trent DW. Emergence of epidemic dengue/dengue hemorrhagic fever as a public health problem in the Americas. Infect Agents Dis. 1993; 2:383- 393.
11. Ganeshkumar P, Murhekar MV, Poornima V, Saravanakumar V, Sukumaran K, Anandaselvasankar A, John D, Mehendale SM. Dengue infection in India: A systematic review and meta-analysis. PLoS neglected tropical diseases. 2018 Jul 16;12(7):e0006618.
12. Khan J, Khan A. Incidence of dengue in 2013: Dengue outbreak in District Swat, Khyber Pakhtunkhwa, Pakistan. IJFBS. 2015; 2(1):50-56.
13. Kumar R, Tripathi P, Tripathi S, Kanodia A, Venkatesh V Prevalence of dengue infection in north Indian children with acute hepatic failure.Ann Hepatol. 2008 Jan-Mar; 7(1):59-62.
14. Souza Ljd, Alves JG, Nougueira RMR, Gicovate Neto C, Bastos DA, Siqueira EWds, et al. Aminotransferase changes and acute hepatitis in patents with Dengue fever: analysis of 15,85 cases. Brazilian J Infect Dis 2004; 8:156-63.
15. Wong M, Shen E. The utility of liver function test in Dengue.Ann Acad Med Singapore 2008; 370:82-3.
16. Trung DT, Le Thi, Thu Thao TT, Hien NTH, Vinh NN, Hien PTD, Chinh NT, et al. Liver involvement associated with dengue infection in adults in Vietnam. Am J Trop Med Hyg 2010; 83:774-80.
17. Asim Ahmed, Aftab Haider Alvi, Ambreen Butt, Arif Amir Nawaz and Asif Hanif. Assessment of Dengue Fever Severity ThroughLiver Function Tests. Journal of the College of Physicians and Surgeons Pakistan 2014, Vol. 24 (9): 640-644
Copyright (c) 2021 Hassan Mumtaz, Irfan Afzal Mughal, Amna Faruqi, Noor -ul-Ain Irfan, Shamim Mumtaz, Asma Irfan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
All research articles published in the Journal of Rawalpindi Medical College (JRMC) are fully open access: immediately freely available to read, download, and share. Copyrights of all articles published in JRMC are retained by the authors. First publication rights are granted to JRMC. The journal/publisher is not responsible for subsequent uses of the work.
All articles are published under the Creative Commons Attribution (CC BY-SA 4.0) license.